Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Case 5

Download as pptx, pdf, or txt
Download as pptx, pdf, or txt
You are on page 1of 28

CASE PRESENTATION

CSU JI Kneekie M. Borromeo


CLINICAL DATA
35 YEAR OLD, MALE
CHIEF COMPLAINT: TESTICULAR MASS
HISTORY
● 6 months PTA, the patient noted with a marble sized painless mass on his
right testis. No consult done.
● 3 months PTA, the mass is gradually enlarging. Still no consult done.
● 2 months PTA, still with the growing mass. Now approximately 4 cm. Still
no consult done.
● 1 month PTA, due to progressing testicular mass. The patient prompted
consult where ultrasound was done revealing homogeneous hypoechoic solid
mass.
PROCEDURE DONE

Right radical orchiectomy


GROSS PICTURE

Well demarcated, homogeneous,


Lobulated soft brown tissue tumor solid tan with surface nodularity and
lobulation
MICROSCOPIC

The tumor cells are arranged in small nests or trabeculae separated


by delicate fibrous septa containing lymphocytes.
MICROSCOPIC
● Round to polyhedral cells with distinct
cell borders
● lymphocytic infiltrate within fibrous
septa.
● Cytoplasm are clear to amphophilic.
● Nuclei are polygonal and may have a flat
edge giving a squared off appearance.
● Large nuclei and prominent nucleoli
SALIENT FEATURES
● 35yo, Male
● Progressing testicular painless mass
● Ultrasound: Homogeneous hypoechoic mass
● Gross: Well demarcated, homogeneous solid tan mass
● Microscopic:
❖ tumor cells are arranged in small nests separated by delicate fibrous septa
containing lymphocytes
❖ Cytoplasm are clear to amphophilic.
❖ Nuclei are polygonal and may have a flat edge giving a squared off appearance
❖ Large nuclei and prominent nucleoli
Differential Diagnosis
Take-off point: Testicular Mass
1. Yolk Sac Tumor
2. Spermatocytic Tumor
3. Embryonal Carcinoma
YOLK SAC TUMOR
Germ cell neoplasm composed of cells / structures reminiscent of
embryonic / fetal yolk sac, allantois and extraembryonal mesenchyme.

● Testicular Mass ● 35 yo

Microscopic: Microscopic:
● (-) Schiller-Duval Bodies
● Sheets of polygonal clear to amphophilic
cells
● Solid nests or trabeculae of polygonal Radiology: heterogeneous echogenicity
eosinophilic cells
● Large nuclei and prominent nucleoli
Gross:
● Poorly circumscribed, nonencapsulated, predominantly solid
● (-) Hemorrhage, necrosis
SPERMATOCYTIC TUMOR
is a polymorphous triphasic germ cell neoplasm recapitulating
spermatogonia development and unrelated to germ cell neoplasia in situ
(GCNIS)

● 35 yo Microscopic:
● (-) Tripartite cytology
● (+) Fibrous Septa
● Painless testicular mass
● (+) Lymphocytic infiltrate

● GROSS: Homogenous, lobulated Radiology: heterogeneous signal,


nodule including hyperechoic and hypoechoic
components

● GROSS: (-) Hemorrhage and


Necrosis
Embryonal Carcinoma
Malignant germ cell tumor composed of primitive epithelial tumor cells
recapitulating early stages of embryonic development

● 35 yo, Microscopic:
● indistinct cell borders with nuclear
overlapping
● Painless testicular mass
● (+) Fibrous Septa
● (+) Lymphocytic infiltrate

GROSS: Poorly circumscribed with


hemorrhage and necrosis
TESTICULAR
SEMINOMA
Seminomas are the most common type of germ cell tumor, making up
about 50% of these tumors. The peak incidence is the third decade
and they almost never occur in infants.
CASE DISCUSSION
ANATOMY OF THE TESTIS
Testis
● Ellipsoid-shaped
● Composed of ∼ 600 seminiferous tubules,
which connect to the rete testis
● Surrounded by a thick capsule (tunica
albuginea)
● Connect to the abdominal wall via the
spermatic cord
Testicular lobules
● Interlobular septa divide the testis into
testicular lobules.
● Each testicular lobule contains 1–4
seminiferous tubules.
MICROSCOPIC

SPERMATIDS
PRIMARY AND
SECONDARY
SPERMATOCYTE
SPERMATOGONIA

BM OF
SEMINIFEROUS
TUBULES

LEYDIG cell
MICROSCOPIC
ETIOLOGY
● Unknown but is associated with the following risk factors:
● Cryptorchidism
● Genetics- family history of testicular CA
● Environmental factors
○ history of testicular trauma
○ being overweight or obese (increased BMI)
○ exposure to estrogens during prenatal development
○ immunosuppression
PATHOGENESIS
CLINICOPATHOLOGIC FEATURES

● Painless enlargement of the testis


● Sensation of heaviness
● Acute testicular pain from intratesticular hemorrhage in around 10%
● Metastatic disease symptoms in around 10%
● Asymptomatic presentation in around 10% of cases
● Elevated serum human chorionic gonadotropin (hCG) levels
● Minimal AFP elevations
GROSS FINDINGS

Seminoma of the testis appears as


a fairly well-circumscribed, pale,
fleshy, homogeneous mass
MICROSCOPIC FINDINGS

The classic seminoma cell is large and round to polyhedral and has a distinct cell
membrane; clear or watery-appearing cytoplasm; and a large, central nucleus with
one or two prominent nucleoli
IMMUNOHISTOCHEMICAL FEATURES

● Seminoma contain isochromosome 12p and express OCT3/4 and NANOG


● Seminoma cells may also stain positively for placental alkaline phosphatase
(PLAP)
● KIT activating mutations
● A few scattered keratin-positive cells may also be present.
RADIOLOGIC FINDINGS
PROGNOSIS
● Currently, all stages have at least a 90% cure rate
Cure rates by stage are as follows:
● Stage I: 98%-100%
● Stage II (B1/B2 nonbulky): 98%-100%
● Stage II (B3 bulky) and stage III: 90% complete response to chemotherapy and
86% durable response rate to chemotherapy.
TREATMENT
● Orchiectomy provides both diagnosis and therapy. Orchiectomy alone cures most stage I
seminomas.
Preferred treatments for more advanced stages are as follows:
● Stage IIA - Radiotherapy or chemotherapy with bleomycin, etoposide, and cisplatin (BEP) or
etoposide and cisplatin (EP)
● Stage IIB - Chemotherapy (preferred) with BEP or EP or radiotherapy in select non-bulky (≤3
cm) cases
● Stage IIC, III (good risk) - Chemotherapy with BEP (category 1) or EP (category 1)
● Stage IIC, III (high risk) - Chemotherapy with BEP (category 1) or etoposide, mesna,
ifosfamide and cisplatin (VIP)
STAGING
THANK YOUUU!

You might also like